Evidence map›Paper›PMID 33729523›Full record

ArticleThe International journal of pharmacy practice2021

The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge.

Nadia Al Mazrouei, Rana M Ibrahim, Ahmad Z Al Meslamani, Derar H Abdel-Qader, Adel Shaban Sadeq, Osama Mohamed Ibrahim

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The International journal of pharmacy practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Expanded roles of community pharmacists in COVID-19: A scoping literature review.Journal of the American Pharmacists Association : JAPhA
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Nadia Al MazroueiDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, UAE.
Rana M IbrahimCollege of Pharmacy, Al Ain University of Science and Technology, Abu Dhabi, UAE.
Ahmad Z Al MeslamaniFaculty of Pharmacy & Medical Sciences, University of Petra, Amman, Jordan.
Derar H Abdel-QaderFaculty of Pharmacy & Medical Sciences, University of Petra, Amman, Jordan.
Adel Shaban SadeqCollege of Pharmacy, Al Ain University of Science and Technology, Abu Dhabi, UAE.
Osama Mohamed IbrahimDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, UAE.
Al Ain University · AEPetra University · JOCairo University · EGUniversity of Sharjah · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate community pharmacists' knowledge about COVID-19 and their preparedness for the pandemic.

methodsThis cross-sectional online survey was conducted (in community pharmacies in the United Arab Emirates) over 3 weeks (24 May 2020 to 14 June 2020). A proportionate random sample of 491 participants was invited to take part. The SPSS version 26 was used for data management and analysis. KEY

findingsThe majority of participants (n = 400) had good knowledge about COVID-19 and high level of preparedness for the pandemic control. Most pharmacists agreed (212, 53.0%) or strongly agreed (91, 22.8%) that they have a major role in the management of the ongoing crisis. Most participants had good awareness about the most common methods of COVID-19 transmission (359, 89.7%) and symptoms encountered (368, 92.0%). However, approximately a quarter of participants (103, 25.7%) incorrectly thought COVID-19 was caused by a DNA virus. Participants who had 5-10 and >10 years of experience were 3.95 (P = 0.03) and 1.59 (P = 0.01) times, respectively, were more likely to have good knowledge compared to participants with less than 2 years of experience. Those with good knowledge were more likely to have a specific area for customers with suspected COVID-19 symptoms compared to those with poor knowledge (P = 0.031).

conclusionThis study indicates that years of experience and good knowledge on COVID-19 were significant determinants of pharmacists' preparedness for the pandemic control.

Indexed as

Community Pharmacy ServicesCOVID-19PandemicsPharmacistsAdultCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedSocioeconomic FactorsSurveys and QuestionnairesUnited Arab Emiratescommunity pharmacistsCOVID-19preparednessUAE

Identifiers

PMID33729523
PMCPMC7799105
OpenAlexW3123283182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.